OOIR: Observatory of International Research

Papers

(The TQCC of World Psychiatry is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Mental health services on the roof of the world	595
Rediscovering the mental health of populations	341
Systems‐based approaches to mental disorders are the only game in town	292
Sustainable Technology for Adolescents and youth to Reduce Stress (STARS): a WHO transdiagnostic chatbot for distressed youth	286
	284
WPA Secretariat's work during the COVID‐19 pandemic	258
Victimization in people with severe mental health problems: the need to improve research quality, risk stratification and preventive measures	250
What is good acute psychiatric care (and how would you know)?	222
A Minimum Service Package (MSP) to improve response to mental health and psychosocial needs in emergency situations	214
Social determinants of health and selection bias in genome‐wide association studies	193
Searching for biomarkers in the fluidity of mental ill‐health	156
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	147
Trends, advances and directions in cognitive‐behavioral therapy for adolescent anxiety	142
Complexities of treatment‐resistant depression: cautionary notes and promising avenues	139
WPA communications under reorganization	138
WPA scientific publications in the triennium 2020‐2023	135
Anomalies of language in schizophrenia: a trajectory of mathematical and computational analyses	131
Philosophy of psychiatry as study of paradigm changes	128
Launching the social philosophy of psychiatry	125
The promise of social recovery therapy in non‐affective psychoses	119
	118
Violence and schizophrenia: the role of social determinants of health and the need for early intervention	114
WPA Volunteering Programme: a pilot project in Mexico	114
WPA educational initiatives: reaching different stakeholders in the mental health field	112
How computational psychiatry can advance the understanding and treatment of obsessive‐compulsive disorder	108

The WPA Section on Preventive Psychiatry: report on 2014‐2024 activities	101
The WPA Global Study on Psychiatric Training	97
The promise of ICD‐11‐defined PTSD and complex PTSD to improve care for trauma‐exposed populations	97
Trauma, coloniality and survivance among Indigenous peoples in the US	88
Vulnerability to addictive behaviors: the Associational Memory‐Appetitive Systems Relations Model	87
The 988 Suicide and Crisis Lifeline in the US: status of evidence on implementation	86
The WHO EQUIP Foundational Helping Skills Trainer's Curriculum	82
From inter‐brain connectivity to inter‐personal psychiatry	81
The need to focus on perfectionism in suicide assessment, treatment and prevention	80
Rationale for and usefulness of the inclusion of gaming disorder in the ICD‐11	76
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis	76
World Health Organization's low‐intensity psychosocial interventions: a systematic review and meta‐analysis of the effects of Problem Management Plus andStep‐by‐Step	75
Subjectivity, psychosis and the science of psychiatry	73
Psychiatric care in oncology and palliative medicine: new challenges and future perspectives	69
Detecting and managing non‐suicidal self‐damaging behaviors	69
The need for a consensual definition of mental health	68
Biomarkers for clinical use in psychiatry: where are we and will we ever get there?	66
Addressing social determinants of mental health: a new era for prevention interventions	61
The promise of evolutionary psychiatry	51
	50
Evidence‐informed is not enough: digital therapeutics also need to be evidence‐based	50
The efficacy of complicated grief therapy for DSM‐5‐TR prolonged grief disorder	48
Childhood gender non‐conformity, sexual orientation and mental health problems among 18 to 89 year‐old Danes	47
First evidence of a general disease (“d”) factor, a common factor underlying physical and mental illness	46
R. Spitzer and the depathologization of homosexuality: some considerations on the 50th anniversary	46
The challenges of defining and managing treatment‐resistant depression in research and practice	43
Designing and delivering mental health literacy strategies in elite sport	42
The WPA Code of Ethics for Psychiatry	41
Aligning the “single law” proposal to the CRPD standard of “will and preferences”	41
The critical distinction between suicidal ideation and suicide attempts	40
Prevention in psychiatry: a role for epigenetics?	39
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum	39
The WHO Flexible Interview for ICD‐11 (FLII‐11)	39
A question of continuity: a self‐determination theory perspective on “third‐wave” behavioral theories and practices	39
Cumulative remission rate after sequential treatments in depression: reappraisal of the STAR*D trial data	37
Patterns and correlates of patient‐reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys	36
Cyberbullying: next‐generation research	36
The epidemic of fentanyl misuse and overdoses: challenges and strategies	34
Treatment‐resistant depression invites persistent reflection	34
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	34
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the UHR 1000+ cohort	33
New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications	32
Prevention, treatment and care of substance use disorders in times of COVID‐19	31
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management	31
The curse and opportunity of heterogeneity in the pursuit of psychiatric biomarkers	31
Action Plan of the WPA Secretary for Scientific Meetings (2023‐2026)	30
How should psychotherapy proceed when adjoined with psychedelics?	30
WPA Working Group on Medical Students: current initiatives and future priorities	30
Functional neurological disorder: defying dualism	29
From diversity to individualized care: Africa’s contribution to psychiatry	27

	26
Promoting schizophrenia research in Europe: the contribution of the European Group for Research in Schizophrenia	24
The importance of listening to patient preferences when making mental health care decisions	24
Cognitive behavioral therapy, process‐based approaches, and evolution in the context of physical health	23
Real changes can enhance information yield on novel psychopharmacologic agents	22
Implementation of the WPA Action Plan 2020‐2023	22
The 2021‐2024 Work Plan of WPA Collaborating Centres	22
Do we really need a process‐based approach to psychotherapy?	22
Estimating the reproducibility of psychotherapy effects in mood and anxiety disorders: the possible utility of multicenter trials	21
WPA Working Group on Defining and Managing Autism Spectrum Disorder: spreading knowledge for the next generations of psychiatrists	21
Implementing 21st century “end‐to‐end” and technology‐enhanced care for young people	20
Nurturing the next generation of clinician‐scientists in child and adolescent psychiatry: recommendations from a WPA Presidential Task Force	20
Impact of displacement on mental health in war‐exposed Ukrainian adolescents: a longitudinal study	19
The “Meet the WPA Council” Panel at the 21st World Congress of Psychiatry	19
Five conceptual competences in psychiatry	19
Association between stressful life events and psychosis relapse: a 2‐year prospective study in first‐episode psychosis	19
What exactly is post‐traumatic stress disorder?	19
Klerman's “credo” reconsidered:neo‐Kraepelinianism, Spitzer's views, and what we can learn from the past	19
The lived experience of postpartum depression and psychosis in women: a bottom‐up review co‐written by experts by experience and academics	18
	18
The paradox of the biopsychological and sociocultural levels in post‐traumatic stress disorder	18
Minimal clinically important difference in obsessive‐compulsive disorder	17
The role of the WPA Collaborating Centres in promoting mental health education and policy worldwide	17
How common is secondary psychosis? Estimates from a systematic review and meta‐analysis	17
Past, present and future of research on brain energy metabolism in bipolar disorder	17
The role of gamification in digital mental health	16
The challenges of youth mental health: showing the hero out of the panopticon	16
	16
The aggregation of marginal gains: a pragmatic philosophy of clinical care in psychiatry	15
The changing nature of work in the 21st century as a social determinant of mental health	15
Achieving equality, inclusiveness, and cultural sensitivity in mental health (EDIT)	15
The evolving nosology of personality disorder and its clinical utility	15
Process‐based and principle‐guided approaches in youth psychotherapy	15
Report by the WPA Working Group on Developing Partnerships with Service Users and Family Carers (2020‐2023)	15
Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children	15
Incremental integration of nosological innovations is improving psychiatric diagnosis and treatment	15
	15
WPA Scientific Sections 2020‐2023: from strengthened backbone to motor of innovation	14
Some priorities in targeting social determinants to achieve prevention of mental disorders	14
The evolving epidemiology and differential etiopathogenesis of eating disorders: implications for prevention and treatment	14
Update on WPA Scientific Meetings	14
The WPA Action Plan 2023‐2026	14
Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom‐specific approach	14
Update on WPA Scientific Meetings	14
Learning from the global response to COVID‐19 to accelerate innovation in mental health trials	14